Bioxcel Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.0k | 1.4k | 2.95 |
| 2023-09-30 | $3.4k | 1.4k | 2.53 |
| 2023-06-30 | $9.0k | 1.4k | 6.66 |
| 2023-03-31 | $25k | 1.4k | 18.66 |
| 2022-12-31 | $42k | 1.4k | 30.98 |
| 2022-09-30 | $15k | 1.4k | 11.11 |
| 2022-06-30 | $17k | 1.4k | 12.59 |
| 2022-03-31 | $28k | 1.4k | 20.74 |
| 2021-12-31 | $27k | 1.4k | 20.00 |
| 2021-09-30 | $33k | 1.1k | 30.56 |
| 2021-06-30 | $31k | 1.1k | 28.70 |
| 2021-03-31 | $47k | 1.1k | 43.52 |
| 2020-12-31 | $43k | 935 | 45.99 |
| 2020-09-30 | $41k | 935 | 43.85 |
| 2020-06-30 | $50k | 935 | 53.48 |
| 2020-03-31 | $12k | 531 | 22.60 |
| 2019-12-31 | $8.0k | 531 | 15.07 |
| 2019-09-30 | $4.0k | 531 | 7.53 |
| 2019-06-30 | $6.0k | 531 | 11.30 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors